Literature DB >> 17291388

Formation of oligosaccharides in skim milk fermented with mixed dahi cultures, Lactococcus lactis ssp diacetylactis and probiotic strains of lactobacilli.

Hariom Yadav1, Shalini Jain, Pushpalata Ravindra Sinha.   

Abstract

Milk fermented with mixed dahi cultures NCDC167, Lactococcus lactis ssp diacetylactis NCDC60 and two probiotic strains; Lactobacillus acidophilus NCDC14 and Lb. casei NCDC19 were evaluated after fermentation (14 h) and during 8 d storage at 7 degrees C. The beta-galactosidase activity was found to increase after fermentation leading to the hydrolysis of lactose and production of glucose, galactose and oligosaccharides; that subsequently decreased during storage. The viable counts of lactococci and lactobacilli decreased during storage yet remained >106 cfu/ml after storage. The results of present study indicate that all the selected cultures have ability to produce oligosaccharides (prebiotics) due to transgalactosidal and lactose hydrolysis activities of beta-galactosidase. The cultures developed an active synbiotic formula by maintaining sufficient probiotic viable counts to exert health benefits to the consumers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291388     DOI: 10.1017/S0022029906002354

Source DB:  PubMed          Journal:  J Dairy Res        ISSN: 0022-0299            Impact factor:   1.904


  3 in total

1.  Fermentation Technology in the Development of Functional Foods for Human Health: Where We Should Head.

Authors:  Hariom Yadav; Shalini Jain; Reza Rastamanesh; Alojz Bomba; Roberto Catanzaro; Francesco Marotta
Journal:  Ferment Technol       Date:  2012-01-30

Review 2.  Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.

Authors:  Christy B Williamson; Cathleen M Burns; Crystal M Gossard; Jessica M Pizano; Keren E Dolan; Heather J Finley; Margaret G Gasta; Emily C Parker; Elizabeth A Lipski
Journal:  Integr Med (Encinitas)       Date:  2017-02

Review 3.  Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.

Authors:  Manoj Kumar; Ravinder Nagpal; Rajesh Kumar; R Hemalatha; Vinod Verma; Ashok Kumar; Chaitali Chakraborty; Birbal Singh; Francesco Marotta; Shalini Jain; Hariom Yadav
Journal:  Exp Diabetes Res       Date:  2012-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.